Moshe Talpaz

19PUBLICATIONS
112CO-AUTHORS
Haematological tumoursMolecular targetsMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 16, 2026
Asciminib monotherapy in patients with BCR::ABL1 T315I-mutated chronic-phase chronic myeloid leukemia: phase 1 trial final results.

|Jul 02, 2026
Choline-dependent methionine metabolism supports leukemia progression.

|May 22, 2026
From fatal disease to functional cure: 25 years of tyrosine kinase inhibition in chronic myeloid leukemia.

|Apr 15, 2026
Activity of PROTAC MDM2 degrader in primary leukemia cells and PDX models.

|Mar 10, 2026
Small molecule screening identifies cytotoxic endoplasmic reticulum-associated degradation inhibitors in multiple myeloma.

Erin M Kropp, Sho Matono, Olivia Y Wang

|Sep 19, 2025
Understanding the Functional Dependence and Inhibition of the Bcl‑2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision Medicine.

Karson J Kump, Ejaz Ahmad, Charles Foucar

Pageof 4

Frequent Collaborators

5 joint publications

Jorge E Cortes

5 joint publications

Malathi Kandarpa

3 joint publications

John Mascarenhas

3 joint publications

Jean-Jacques Kiladjian